In the last 12 months, insiders at Nuvectis Pharma made open-market purchases of $2.29 million (246.27K shares) and sold no shares on the open market.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ron Bentsur | Chairman Ceo | 6,513,883 | 0 | 6,513,883 | 39.5% | 01 Jul, 2026 |
| 2 | Marlio Charles Mosseri | TenPercentOwner | 0 | 3,186,576 | 3,186,576 | 19.3% | 01 Jul, 2026 |
| 3 | Enrique Poradosu | Chief Science Business Off | 3,003,968 | 0 | 3,003,968 | 18.2% | 09 Jan, 2026 |
| 4 | Shay Shemesh | Chief Dev. Ops. Officer | 2,972,683 | 0 | 2,972,683 | 18.0% | 09 Jan, 2026 |
| 5 | Michael J. Carson | Vice President, Finance | 230,118 | 0 | 230,118 | 1.4% | 05 Aug, 2026 |
| 6 | Kenneth Hoberman | Director | 168,140 | 0 | 168,140 | 1.0% | 12 Jun, 2026 |
| 7 | Matthew L. Kaplan | Director | 159,760 | 0 | 159,760 | 1.0% | 12 Jun, 2026 |
| 8 | James F Iii Oliviero | Director | 122,828 | 0 | 122,828 | 0.7% | 12 Jun, 2026 |
| 9 | Juan Sanchez | Director | 113,380 | 0 | 113,380 | 0.7% | 12 Jun, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 03 Aug, 2026 | Michael J. Carson | Vice President, Finance | Acquired A | 30,000 | $0.00 | $0 | 230,118 | Direct |
| 30 Jun, 2026 | Marlio Charles Mosseri | TenPercentOwner | Acquired P | 50,000 | $18.32 | $916.00K | 3,186,576 | Indirect |
| 30 Jun, 2026 | Ron Bentsur | Chairman Ceo | Acquired P | 12,500 | $20.00 | $250.00K | 3,688,424 | Direct |
| 11 Jun, 2026 | Matthew L. Kaplan | Director | Acquired A | 35,000 | $0.00 | $0 | 159,760 | Direct |
| 11 Jun, 2026 | Kenneth Hoberman | Director | Acquired A | 35,000 | $0.00 | $0 | 168,140 | Direct |
| 11 Jun, 2026 | Juan Sanchez | Director | Acquired A | 35,000 | $0.00 | $0 | 113,380 | Direct |
| 11 Jun, 2026 | James F Iii Oliviero | Director | Acquired A | 35,000 | $0.00 | $0 | 122,828 | Direct |
| 06 Jan, 2026 | Ron Bentsur | Chairman Ceo | Acquired A | 150,000 | $0.00 | $0 | 3,675,924 | Direct |
| 06 Jan, 2026 | Michael J. Carson | Vice President, Finance | Acquired A | 61,200 | $0.00 | $0 | 200,118 | Direct |
| 06 Jan, 2026 | Shay Shemesh | Chief Dev. Ops. Officer | Acquired A | 150,000 | $0.00 | $0 | 1,793,068 | Direct |
| 06 Jan, 2026 | Enrique Poradosu | Chief Science Business Off | Acquired A | 150,000 | $0.00 | $0 | 1,806,319 | Direct |
| 05 Nov, 2025 | Juan Sanchez | Director | Acquired P | 13,000 | $5.79 | $75.27K | 78,150 | Direct |
| 05 Nov, 2025 | Ron Bentsur | Chairman Ceo | Acquired P | 5,000 | $5.72 | $28.60K | 3,525,924 | Direct |
| 05 Nov, 2025 | Matthew L. Kaplan | Director | Acquired P | 11,000 | $5.84 | $64.24K | 124,760 | Direct |
| 22 Sep, 2025 | Juan Sanchez | Director | Acquired A | 30,000 | $0.00 | $0 | 65,150 | Direct |
| 23 Oct, 2025 | Marlio Charles Mosseri | TenPercentOwner | Acquired P | 46,900 | $6.06 | $284.21K | 3,028,706 | Indirect |
| 24 Oct, 2025 | Marlio Charles Mosseri | TenPercentOwner | Acquired P | 35,034 | $6.15 | $215.46K | 3,063,740 | Indirect |
| 27 Oct, 2025 | Marlio Charles Mosseri | TenPercentOwner | Acquired P | 72,836 | $6.28 | $457.41K | 3,136,576 | Indirect |
| 20 Jun, 2025 | Marlio Charles Mosseri | TenPercentOwner | Acquired P | 5,603 | $7.99 | $44.77K | 2,981,806 | Indirect |
| 17 Jun, 2025 | Marlio Charles Mosseri | TenPercentOwner | Acquired P | 5,399 | $8.11 | $43.79K | 2,948,160 | Indirect |